MedTrace Logo

Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery

NCT04711837 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 255

Last updated 2025-10-10

Study results available
· View outcomes & findings →

Summary

This is a multicenter, randomized, double-blinded, propofol-controlled, Phase 3 clinical study to evaluate the efficacy and safety of HSK3486 for induction of general anesthesia in adults undergoing elective surgery.

Conditions

  • Anesthesia

Interventions

DRUG

HSK3486

HSK3486 for induction of general anesthesia.

DRUG

Propofol

Propofol for induction of general anesthesia.

Sponsors & Collaborators

  • Haisco-USA Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • William Daley, MD · Haisco-USA Pharmaceuticals, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-11
Primary Completion
2022-04-13
Completion
2022-04-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04711837 on ClinicalTrials.gov